Table 3.

Follow-up and outcomes

	Scan +ve (n = 78) n (%)	Scan −ve with root compression (n = 87) n (%)	P value	Scan −ve no root compression (n = 104) n (%)	P value
Average follow-up/months	13	16		16
No follow-up	10 (13%)	6 (7%)		12 (11%)
Deceased or palliative	4			1
Cause of clinical CES found	100%	0		1 (1%)
Re-presentation with clinical CES
Once	3 (4%)	10 (11%)		12 (11%)
Twice	3 (4%)	8 (9%)		7 (7%)
Three times	N/A	2 (2%) 2 (2%)		3 (3%) 2 (2%) 3 (3%)
Prior ‘scan-positive’ CES	2 (3%)	3 (3%)		2 (2%)
Prior ‘scan-negative’ CES		6 (7%)		9 (9%)
Chronic pain	20 (27%)	52 (60%)	< 0.0001	60 (58%)	< 0.0001
Bladder disorders
Total affected	8 (10%)	8 (9%)		11 (11%)
Storage problems
Neurogenic bladder	7 (9%)	0		0
Overactive bladder	1 (1%)	1 (1%)		1 (1%)
Stress incontinence		1 (due to prolapse)		0
Urge incontinence		0		2 (2%)
Voiding problems
Idiopathic urinary retention		1 (1%)		3 (3%)
Urethral stenosis		1(1%)		2 (2%)
BPH		1 (1%)		1(1%)
Other		1 (1%)UTI 2 idiopathic haematuria		1 bladder outlet obstruction 1 enuresis
Timing of urological diagnoses Before CES presentation
Stress urinary incontinence	2 (3%)	1 (1%)		4 (4%)
Urge incontinence	1 (1%)			2 (2%)
Idiopathic urinary retention		1 (1%)		1 (1%)
Bladder outlet obstruction	1 (1%)			1 (1%)
At time of diagnosis	0	1 (1%) UTI		0
After CES presentation	6 (8%)	6 (7%)		7 (7%)

Bold—P values of < 0.05 were deemed significant